Posted by Michael Wonder on 25 Nov 2017
EU Ombudsman confirms EMA’s correct handling of declared interests
24 November 2017 - Latest decision concludes no maladministration at EMA.
The EMA welcomes the decision by the European Ombudsman, Emily O’Reilly, that there was no maladministration in its handling of the declaration of interests of its Executive Director.
The Ombudsman's review followed a complaint by the Nordic Cochrane organisation and other individuals, who reported allegedly undeclared interests of EMA’s Executive Director Guido Rasi, relating to certain pharmaceutical patents for which he was named as co-inventor, and raised concerns over EMA’s handling of these.
Following a complaint from the same reporting sources, the Ombudsman had already concluded in October 2017 that there was no maladministration by the Agency in the handling of its safety review of human papillomavirus vaccines.
